Holdings of Select Biotechnology Portfolio
Fidelity Select Portfolios · Original filing · Compare with another fund · Report an error
- Net assets
- 5.3B $ including 5.2B $ in equities, 98.0 %
- Positions
- 169 in 15 countries
- Top ten
- 45.1 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Krystal Biotech Inc | 1,802,622 | 557.1M $ | 10.58 % |
| 2 | AbbVie Inc | 2,230,183 | 485.6M $ | 9.22 % |
| 3 | Amgen Inc | 1,020,981 | 343.9M $ | 6.53 % |
| 4 | Gilead Sciences Inc | 1,886,298 | 253.6M $ | 4.82 % |
| 5 | ALNYLAM PHARMACEUTICALS INC | 511,683 | 154.5M $ | 2.93 % |
| 6 | Praxis Precision Medicines Inc | 371,429 | 130M $ | 2.47 % |
| 7 | Insmed Inc | 1,109,201 | 118.6M $ | 2.25 % |
| 8 | Argenx SE | 141,444 | 118.2M $ | 2.25 % |
| 9 | Ascendis Pharma A/S | 480,401 | 107.7M $ | 2.04 % |
| 10 | REVOLUTION MEDICINES INC | 675,072 | 106.3M $ | 2.02 % |
| 11 | UCB SA | 357,874 | 105.1M $ | 2.00 % |
| 12 | JAZZ PHARMACEUTICALS PLC | 410,452 | 97.1M $ | 1.84 % |
| 13 | Scholar Rock Holding Corp | 1,650,449 | 81.4M $ | 1.55 % |
| 14 | NATERA INC | 331,532 | 74.1M $ | 1.41 % |
| 15 | MODERNA INC | 1,432,529 | 67.6M $ | 1.28 % |
| 16 | Axsome Therapeutics Inc | 286,580 | 67.2M $ | 1.28 % |
| 17 | Biogen Inc | 338,835 | 66.4M $ | 1.26 % |
| 18 | Protagonist Therapeutics Inc | 607,713 | 60.5M $ | 1.15 % |
| 19 | Roivant Sciences Ltd | 1,982,419 | 59.5M $ | 1.13 % |
| 20 | COGENT BIOSCIENCES INC | 1,604,794 | 56.1M $ | 1.07 % |
| 21 | Tango Therapeutics Inc | 2,339,362 | 51.4M $ | 0.98 % |
| 22 | Celcuity Inc | 375,600 | 49.9M $ | 0.95 % |
| 23 | Madrigal Pharmaceuticals Inc | 98,095 | 48.8M $ | 0.93 % |
| 24 | Bridgebio Pharma Inc | 707,304 | 46.9M $ | 0.89 % |
| 25 | Immunome Inc | 2,131,664 | 46.5M $ | 0.88 % |
| 26 | United Therapeutics Corp | 82,591 | 46M $ | 0.87 % |
| 27 | KYMERA THERAPEUTICS INC | 556,441 | 45.3M $ | 0.86 % |
| 28 | ArriVent Biopharma Inc | 1,439,803 | 43.6M $ | 0.83 % |
| 29 | Candel Therapeutics Inc | 4,864,753 | 40.4M $ | 0.77 % |
| 30 | Stoke Therapeutics Inc | 1,293,694 | 40M $ | 0.76 % |
| 31 | Dianthus Therapeutics Inc | 420,518 | 39.1M $ | 0.74 % |
| 32 | TRAVERE THERAPEUTICS INC | 798,843 | 37.7M $ | 0.72 % |
| 33 | IONIS PHARMACEUTICALS INC | 476,377 | 36.4M $ | 0.69 % |
| 34 | DYNE THERAPEUTICS INC | 1,883,544 | 36.4M $ | 0.69 % |
| 35 | Galderma Group AG | 168,890 | 35.7M $ | 0.68 % |
| 36 | Corcept Therapeutics Inc | 506,746 | 35.2M $ | 0.67 % |
| 37 | CYTOKINETICS INC | 449,175 | 34.5M $ | 0.65 % |
| 38 | ABIVAX SA | 255,300 | 33.9M $ | 0.64 % |
| 39 | Trevi Therapeutics Inc | 2,374,785 | 33.6M $ | 0.64 % |
| 40 | ORUKA THERAPEUTICS INC | 562,683 | 32.9M $ | 0.63 % |
| 41 | Apogee Therapeutics Inc | 398,657 | 32.7M $ | 0.62 % |
| 42 | Erasca Inc | 2,533,680 | 32.5M $ | 0.62 % |
| 43 | Arrowhead Pharmaceuticals Inc | 409,378 | 31.9M $ | 0.61 % |
| 44 | Disc Medicine Inc | 454,774 | 31.6M $ | 0.60 % |
| 45 | Crinetics Pharmaceuticals Inc | 886,871 | 31.5M $ | 0.60 % |
| 46 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 637,600 | 30.8M $ | 0.59 % |
| 47 | Nuvalent Inc | 273,399 | 30.2M $ | 0.57 % |
| 48 | Spyre Therapeutics Inc | 403,153 | 29.6M $ | 0.56 % |
| 49 | Annexon Inc | 5,082,296 | 27.5M $ | 0.52 % |
| 50 | Intellia Therapeutics Inc | 1,914,833 | 26.9M $ | 0.51 % |
| 51 | VAXCYTE INC | 474,755 | 24.4M $ | 0.46 % |
| 52 | Edgewise Therapeutics Inc | 699,425 | 23.9M $ | 0.45 % |
| 53 | VIRIDIAN THERAPEUTICS INC | 1,308,304 | 23.1M $ | 0.44 % |
| 54 | ARCUS BIOSCIENCES INC | 852,700 | 21.6M $ | 0.41 % |
| 55 | STRUCTURE THERAPEUTICS INC | 542,038 | 21.3M $ | 0.40 % |
| 56 | VIATRIS INC | 1,290,166 | 21M $ | 0.40 % |
| 57 | Allogene Therapeutics Inc | 9,546,893 | 20.7M $ | 0.39 % |
| 58 | Bicara Therapeutics Inc | 944,900 | 20.6M $ | 0.39 % |
| 59 | Maze Therapeutics Inc | 739,660 | 19.6M $ | 0.37 % |
| 60 | Zealand Pharma A/S | 377,990 | 19.2M $ | 0.36 % |
| 61 | Solid Biosciences Inc | 2,606,779 | 19.1M $ | 0.36 % |
| 62 | Xenon Pharmaceuticals Inc | 345,564 | 18.9M $ | 0.36 % |
| 63 | Ideaya Biosciences Inc | 637,957 | 18.8M $ | 0.36 % |
| 64 | Summit Therapeutics Inc | 1,067,669 | 18.7M $ | 0.36 % |
| 65 | VOR BIOPHARMA INC | 1,185,725 | 17.8M $ | 0.34 % |
| 66 | NEWAMSTERDAM PHARMA COMPANY NV | 523,700 | 17.6M $ | 0.33 % |
| 67 | MIRUM PHARMACEUTICALS INC | 170,600 | 17.3M $ | 0.33 % |
| 68 | Rapport Therapeutics Inc | 428,273 | 16.9M $ | 0.32 % |
| 69 | TWIST BIOSCIENCE CORP | 238,825 | 16M $ | 0.30 % |
| 70 | Biohaven Ltd | 1,448,896 | 16M $ | 0.30 % |
| 71 | AMYLYX PHARMACEUTICALS INC | 1,097,175 | 15.7M $ | 0.30 % |
| 72 | MannKind Corp | 4,078,401 | 15.4M $ | 0.29 % |
| 73 | Kailera Therapeutics Inc | 619,399 | 14.2M $ | 0.27 % |
| 74 | Relay Therapeutics Inc | 1,010,467 | 14.2M $ | 0.27 % |
| 75 | uniQure NV | 473,082 | 13.5M $ | 0.26 % |
| 76 | Enliven Therapeutics Inc | 340,067 | 13.5M $ | 0.26 % |
| 77 | ALUMIS INC | 620,000 | 13.4M $ | 0.25 % |
| 78 | Viking Therapeutics Inc | 404,257 | 13.2M $ | 0.25 % |
| 79 | Replimune Group Inc | 1,514,745 | 13.2M $ | 0.25 % |
| 80 | Tectonic Therapeutic Inc | 405,389 | 12.6M $ | 0.24 % |
| 81 | Idorsia Ltd | 2,174,283 | 12.4M $ | 0.24 % |
| 82 | Mineralys Therapeutics Inc | 385,900 | 12.2M $ | 0.23 % |
| 83 | PTC Therapeutics Inc | 160,411 | 11.8M $ | 0.23 % |
| 84 | DAMORA THERAPEUTICS INC | 454,559 | 11.3M $ | 0.21 % |
| 85 | TYRA BIOSCIENCES INC | 337,000 | 11.3M $ | 0.21 % |
| 86 | HEMAB THERAPEUTICS HOLDINGS INC | 379,476 | 10.8M $ | 0.21 % |
| 87 | Forte Biosciences Inc | 563,591 | 10.7M $ | 0.20 % |
| 88 | Eikon Therapeutics Inc | 974,333 | 10.6M $ | 0.20 % |
| 89 | Absci Corp | 1,540,796 | 10.4M $ | 0.20 % |
| 90 | Capricor Therapeutics Inc | 334,200 | 10M $ | 0.19 % |
| 91 | CYTOMX THERAPEUTICS INC | 2,774,340 | 10M $ | 0.19 % |
| 92 | Gubra A/S | 166,002 | 9.3M $ | 0.18 % |
| 93 | IMMUNOVANT INC | 272,221 | 9.1M $ | 0.17 % |
| 94 | Rhythm Pharmaceuticals Inc | 99,803 | 8.8M $ | 0.17 % |
| 95 | vTv Therapeutics Inc | 260,391 | 8.7M $ | 0.16 % |
| 96 | BEONE MEDICINES LTD | 29,698 | 8.6M $ | 0.16 % |
| 97 | Nuvation Bio Inc | 1,758,533 | 8.4M $ | 0.16 % |
| 98 | Hansa Biopharma AB | 2,290,077 | 8.4M $ | 0.16 % |
| 99 | Immunocore Holdings PLC | 287,200 | 8.3M $ | 0.16 % |
| 100 | Olema Pharmaceuticals Inc | 628,100 | 8.3M $ | 0.16 % |
Sector breakdown
- Health care 36.7 %
- Unattributed 63.3 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 96.2 %
- EUR 2.2 %
- CHF 0.9 %
- DKK 0.6 %
- SEK 0.2 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 86.3 %
- Netherlands 3.0 %
- Denmark 2.6 %
- Belgium 2.0 %
- Ireland 2.0 %
- Bermuda 1.2 %
- Switzerland 0.9 %
- France 0.8 %
- Canada 0.4 %
- British Virgin Islands 0.3 %
- Sweden 0.2 %
- Cayman Islands 0.1 %
- Other countries 0.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 143 | 4.5B $ | 86.29 % |
| 2 | Netherlands | 4 | 153.8M $ | 2.98 % |
| 3 | Denmark | 3 | 136.1M $ | 2.64 % |
| 4 | Belgium | 1 | 105.1M $ | 2.04 % |
| 5 | Ireland | 3 | 104.3M $ | 2.02 % |
| 6 | Bermuda | 1 | 59.5M $ | 1.15 % |
| 7 | Switzerland | 2 | 48.2M $ | 0.93 % |
| 8 | France | 2 | 41.9M $ | 0.81 % |
| 9 | Canada | 1 | 18.9M $ | 0.37 % |
| 10 | British Virgin Islands | 1 | 16M $ | 0.31 % |
| 11 | Sweden | 1 | 8.4M $ | 0.16 % |
| 12 | Cayman Islands | 4 | 6.3M $ | 0.12 % |
Cite this page
Titelia. "Holdings of Select Biotechnology Portfolio". https://titelia.com/en/funds/S000007486